Treatment of Cushing’s Disease with Pituitary-Targeting Seliciclib

By sjmartinez • October 11, 2022

Liu NA, Ben-Shlomo A, Carmichael JD, Wang C, Swerdloff RS, Heaney AP, Barkhoudarian G, Kelly D, Noureddin M, Lu L, Desai M, Stolyarov Y, Yuen K, Mamelak AN, Mirocha J, Tighiouart M, Melmed S. Treatment of Cushing's Disease with Pituitary-Targeting Seliciclib. J Clin Endocrinol Metab. 2022 Oct 10:dgac588. doi: 10.1210/clinem/dgac588. Epub ahead of print. PMID: 36214832.

Tags: adrenocorticotrophic hormone, cortisol, Cushing’s disease, Endocrinology, pituitary adenoma, Publications

Efficacy and safety of relacorilant for the treatment of patients with Cushing’s syndrome (GRACE): a multicentre, phase 3, double-blind, placebo-controlled, randomised-withdrawal study

Pivonello R, Arnaldi G, Auchus RJ, Badiu C, Busch RS, Cannavò S, Dischinger U, Dobri GA, Donegan DM, Elenkova A, Fazeli PK, Feelders RA, Garcia-Centeno[...]

Stephanie Smooke Praw, MD Appointed Interim Chief of the UCLA Division of Endocrinology

The UCLA Department of Medicine is delighted to announce that Stephanie Smooke Praw, MD has been appointed interim chief of the UCLA Division of Endocrinology, expanding upon her[...]

Diet, nutrition, and hormone therapy for prostate cancer: a systematic review with implications for future interventions

Pahulu I, Calumpit M, Tominez P, Shih JJ, Ebrahimi S, Deville NV, Samoa R, Moin T, Sedrak MS, Valle LF, Steinberg M, Kishan AU, Ganz[...]